We work hard to attract, retain, and support the most outstanding faculty.
Circulation. Cardiovascular genetics
2009
Cardiology | Volume 115 of Issue 2
2009
Established doxorubicin cardiomyopathy is a lethal disease. When congestive heart failure develops, mortality is approximately 50%. Extensive research has been done to understand the mechanism and pathophysiology of doxorubicin cardiomyopathy, and considerable knowledge and experience has been gained. Unfortunately, no effective treatment for established doxorubicin cardiomyopathy is presently available. Extensive research has been done and is being done to discover preventive treatments. However an effective and clinically applicable preventive treatment is yet to be discovered.
View on PubMedPsychiatry research
2009
Journal of the American Society of Nephrology : JASN
2009
The American journal of cardiology
2009
Medical physics
2009